Price T Rowe Associates Inc. MD Buys 21,494 Shares of Genpact Limited (NYSE:G)

Price T Rowe Associates Inc. MD lifted its stake in Genpact Limited (NYSE:G - Free Report) by 17.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 147,185 shares of the business services provider's stock after acquiring an additional 21,494 shares during the period. Price T Rowe Associates Inc. MD owned approximately 0.08% of Genpact worth $6,323,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. SRH Advisors LLC bought a new position in shares of Genpact in the fourth quarter valued at approximately $26,000. Atlas Capital Advisors Inc. raised its position in Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after purchasing an additional 216 shares during the last quarter. Manchester Capital Management LLC acquired a new position in Genpact in the fourth quarter worth $38,000. GeoWealth Management LLC grew its holdings in shares of Genpact by 199.0% during the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after purchasing an additional 583 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its holdings in shares of Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after buying an additional 783 shares during the last quarter. 96.03% of the stock is owned by institutional investors.

Analyst Ratings Changes

G has been the subject of a number of research reports. Robert W. Baird lowered their price objective on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and boosted their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho raised their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Needham & Company LLC decreased their price objective on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday. Finally, TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and raised their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $48.75.

Insider Transactions at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.07% of the stock is owned by corporate insiders.

Genpact Stock Performance

G traded down $7.35 during trading hours on Thursday, reaching $42.20. The company's stock had a trading volume of 8,071,874 shares, compared to its average volume of 1,360,303. The company's 50-day moving average is $49.14 and its 200-day moving average is $46.89. Genpact Limited has a 52 week low of $30.38 and a 52 week high of $56.76. The firm has a market cap of $7.41 billion, a PE ratio of 14.86, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16.

Genpact (NYSE:G - Get Free Report) last posted its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The company had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. During the same quarter last year, the company posted $0.73 EPS. Genpact's quarterly revenue was up 7.4% compared to the same quarter last year. On average, equities analysts forecast that Genpact Limited will post 3.21 EPS for the current year.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.